MPTP alters central catecholamine neurons in addition to the nigrostriatal system
- 1 December 1984
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 13 (6), 737-742
- https://doi.org/10.1016/0361-9230(84)90234-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmosetNeuroscience Letters, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in miceNeuropharmacology, 1984
- Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTPEuropean Journal of Pharmacology, 1984
- The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and ManCanadian Journal of Neurological Sciences, 1984
- Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Standardization of the sucrose-potassium phosphate-glyoxylic acid histofluorescence method for tissue monoaminesNeuroscience Letters, 1980
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- THE BRAIN-STEM LESIONS IN PARKINSONISMJournal of Neurology, Neurosurgery & Psychiatry, 1953